Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours.
Ecancermedicalscience
; 16: 1421, 2022.
Article
em En
| MEDLINE
| ID: mdl-36158978
ABSTRACT
[This corrects the article on p. 1 in vol. 16.].
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article